Screening for HIV Infection: Risks, Benefits, and the Burden of Proof
Law Medicine and Health CarePublished 1 December 1986
Michael J. Barry, Paul D. Cleary, Harvey V. Fineberg
Citations32
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
Abstract
In 1984, scientists isolated a new pathogen, now called human immunodeficiency virus (HIV), that is almost certainly the etiological agent for the acquired immunodeficiency syndrome (AIDS). It has been estimated that there are between 500,000 and 1,750,000 asymptomatic, chronically HIV-infected individuals in the United States. In a remarkably short time, investigators developed a number of blood tests that indicate whether an individual is likely to be infected with this virus. These assays are now being used to test patients with symptoms suggesting AIDS or related syndromes, to screen donated blood, to evaluate individuals concerned about their infection status, and to screen new military recruits, active-duty soldiers, and ROTC students. Almost weekly, new proposals are advanced for screening different subsets of the population.
Keywords
MedicineHealth Professions
ScienceFrequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS
3,645 Citations1984Robert C. Gallo, Syed Zaki Salahuddin +11 more
Peripheral blood lymphocytes from patients with the acquired immunodeficiency syndrome (AIDS) or with signs or symptoms that frequently precede AIDS (pre-AIDS) were grown in vitro with added T-cell growth factor and assayed for the expression and release of human T-lymphotropic retroviruses (HTLV).
New England Journal of MedicineProblems of Spectrum and Bias in Evaluating the Efficacy of Diagnostic Tests
1,732 Citations1978David F. Ransohoff, Alvan R. Feinstein
To determine why many diagnostic tests have proved to be valueless after optimistic introduction into medical practice, a series of investigations and identified two major problems that can cause erroneous statistical results for the "sensitivity" and "specificity" indexes of diagnostic efficacy.
Operations ResearchClinical Decision Analysis
1,422 Citations1980Baruch Fischhoff
It is hoped that by considering the issues that a related profession has identified, the approaches it has developed to study those issues, and the (partial) conclusions it has reached, this work can facilitate the development of decision analysis.
New England Journal of MedicineIncreased Absenteeism from Work after Detection and Labeling of Hypertensive Patients
519 Citations1978R. Brian Haynes, David L. Sackett +3 more
It is found that absenteeism rose 80 per cent after screening and referral among patients unaware of their hypertension before screening, which greatly exceeded the 9 per cent rise in absenteeism in the general employee population during this period.
New England Journal of MedicineThe Walter Reed Staging Classification for HTLV-III/LAV Infection
514 Citations1986Robert R. Redfield, David C. Wright +1 more
The purpose of the Walter Reed (WR) staging Classification is to provide uniformity for routine clinical evaluation of military personnel with HTLV-III infection, to facilitate understanding of the natural history of these infections, and to help evaluate the clinical response to antiviral treatment regimens.
Annals of Internal MedicineDiagnostic Decision: Probability Theory in the Use of Diagnostic Tests
369 Citations1986Harold C. Sox
Understanding is provided of methods that are useful in formulating advice about when to use diagnostic tests and the limitations of most studies of the sensitivity and specificity of diagnostic tests.
Annals of Internal MedicinePrimary Human T-Lymphotropic Virus Type III Infection
336 Citations1985David D. Ho, M. G. SARNGADHARAN +4 more
Physicians should consider the possibility of primary HTLV-III infection when evaluating patients who belong to one of the risk groups for the acquired immunodeficiency syndrome and who have prolonged febrile illnesses.
The LancetSEROEPIDEMIOLOGICAL STUDIES OF HUMAN T-LYMPHOTROPIC RETROVIRUS TYPE III IN ACQUIRED IMMUNODEFICIENCY SYNDROME
245 Citations1984Bijan Safai, J E Groopman +6 more
Sera screened for antibodies to proteins of the novel human T-lymphotropic retrovirus (leukaemia virus), HTLV-III, recently isolated from cultured T cells of AIDS patients strongly indicate that the antibodies to HT LV are diagnostic of AIDS or indicate significant risk of the disease, and suggest that HT LV is the primary cause of human AIDS.
The LancetHTLV-III IN SYMPTOM-FREE SERONEGATIVE PERSONS
234 Citations1984S. Zaki Salahuddin, PhillipD. Markham +7 more
The occurrence of seronegative but virus-positive persons without clinical symptoms suggests that assays other than those detecting antibody to virus, perhaps based on detection of viral antigens or immune complexes, may be required to identify all infected individuals.
Annals of Internal MedicineThe Acquired Immunodeficiency Syndrome in a Cohort of Homosexual Men
221 Citations1985Harold W. Jaffe, WILLIAM W. DARROW +9 more
JAMAHIV Antibody Screening
143 Citations1986Ronald Bayer
This report focuses on the use of blood tests to identify individuals who have been infected with the retrovirus human immunodeficiency virus (HIV), and follows the terminology recently proposed by the International Committee on the Taxonomy of Viruses.
The LancetSTUDIES OF CELLULAR IMMUNITY IN MALE HOMOSEXUALS IN LONDON
141 Citations1983A J Pinching, D J Jeffries +6 more
The combination of lymphocyte abnormalities and anergy observed in these symptom-free homosexuals may represent a latent phase of AIDS.
The LancetHLA DR4 ANTIBODIES CAUSE POSITIVE HTLV-III ANTIBODY ELISA RESULTS
126 Citations1985P. Kühnl, S. Seidl +1 more
The data suggest that DR4 is present on the H9 cell and also as a contaminant on the HTLV-III antigen coated beads used for ELISA test, and the recognition of DR4 antibodies in the sera of homosexuals and patients on hemodialysis is important in the interpretation of positive HT LV-III antibody ELISA results.
JAMALaboratory and Epidemiologic Evaluation of an Enzyme Immunoassay for Antibodies to HTLV-III
113 Citations1986John W. Ward
The enzyme immunoassays (EIAs) for antibody to human T-cell lymphotropic virus type III (HTLV-III) were rapidly adopted for screening donated blood and plasma and virtually eliminated the use ofBlood and plasma from HTLV- III/LAV infected donors.
JAMAAIDS Serology Testing in Low- and High-Risk Groups
105 Citations1985James R. Carlson
The performance characteristics of the acquired immunodeficiency syndrome (AIDS)-retrovirus serological tests including enzyme-linked immunosorbent assay (ELISA), Western blot, and immunofluorescence assay were defined in a clinical laboratory setting by testing 1,257 serum specimens from low- and high-risk groups for AIDS.
JAMAHuman T-Cell Lymphotropic Virus Type III Infection in a Cohort of Homosexual Men in New York City
105 Citations1986Cladd E. Stevens
The continuing risk of HTLV-III infections in the homosexual population studied is demonstrated and the need for more effective prevention of transmission is emphasized.
The LancetWHICH ANTI-HTLV III/LAV ASSAYS FOR SCREENING AND CONFIRMATORY TESTING?
95 Citations1985Philip P. Mortimer, John Parry +1 more
The commercial assays C, D and E, an antibody capture assay, and a simple immunofluorescence test could be the basis for a methodologically diverse national system of primary and confirmatory testing for anti-HTLV-III/LAV.
Annals of Internal MedicineLicensed Tests for Antibody to Human T-Lymphotropic Virus Type III
92 Citations1985John C. Petricciani
The Public Health Service has issued provisional recommendations regarding the voluntary use of the antibody tests to screen blood and plasma donations on the basis of sensitivity and specificity.
TransfusionDetection of human anti‐HTLV‐III antibodies by indirect immunofluorescence using fixed cells
91 Citations1985E G Sandstrom, Robert T. Schooley +7 more
Investigation of human antibodies by indirect immunofluorescence on acetone‐fixed HTLV‐III infected H9 cells was evaluated in blood donors, patients with infectious or auto‐immune diseases, and men with or at high risk for developing acquired immune deficiency syndrome (AIDS).
Annals of Internal MedicineThe Epidemiology and Prevention of the Acquired Immunodeficiency Syndrome
90 Citations1985James W. Curran
Preventing transmission among sexual partners, among intravenous drug users, and from infected mothers to newborns will continue to be difficult without a vaccine, specific antiviral therapy, or both.
Annals of Internal MedicineExposure to Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus and Immunologic Abnormalities in Asymptomatic Homosexual Men
90 Citations1985Janet K.A. Nicholson, J. STEVEN McDOUGAL +7 more
Multivariate statistical analysis showed that exposure to HTLV-III/LAV was the single best predictor of T-cell (and other) immunologic abnormalities, and the association of other microbial serologic findings with HT LV/L AV seropositivity or T- cell changes was a coincidental function of sexual activity.
BMJVariation in human T lymphotropic virus III (HTLV-III) antibodies in homosexual men: decline before onset of illness related to acquired immune deficiency syndrome (AIDS).
88 Citations1985R J Biggar, Mads Melbye +5 more
Western blot analysis was used to document the development and changes in human T lymphotropic virus III (HTLV-III) antibody among Danish homosexual men followed longitudinally over three years.
Annals of Internal MedicineThe Natural History of Infection with the Lymphadenopathy-Associated Virus Human T-Lymphotropic Virus Type III
73 Citations1985Donald P. Francis, HAROLD W. JAFFE +4 more
Over half of the persons infected with the lymphadenopathy-associated virus/human T-lymphotropic virus type III (LAV/HTLV-III), the retrovirus that causes the acquired immunodeficiency syndrome (AIDS), become persistently infectedwith the virus.
The American Journal of MedicineAssociation of human T lymphotropic virus type III antibodies with sexual and other behaviors in a cohort of homosexual men from Boston with and without generalized lymphadenopathy
64 Citations1986Kenneth H. Mayer, David Ayotte +4 more
The data suggest that educational programs among homosexual men attempting to decrease AIDS risk should focus on decreasing the number of partners, receptive anal intercourse, oral exposure to ejaculate and other intimate rectal contact, and sexual contact with men from areas of increased HTLV-III seroprevalence.
JAMAHTLV-III/LAV Infection in Hemodialysis Patients
61 Citations1986Thomas A. Peterman
It is found that HTLV-III/LAV was not transmitted in the dialysis centers and seropositive patients had low reactivity on enzyme immunoassay, negative results of Western blot tests, and negative cultures.
New England Journal of MedicineFalse Positive Tests for HTLV-III Antibodies in Alcoholic Patients with Hepatitis
40 Citations1986C L Mendenhall, Gary A. Roselle +3 more
It is demonstrated that patients with alcoholic liver disease have a high incidence of false positives on tests for HTLV-III antibodies, and it is important to recognize so that these patients are not falsely identified as having previous infection with HT LV-III.
Annals of Internal MedicineTransient Antibody to Lymphadenopathy-Associated Virus/Human T-Lymphotropic Virus Type III and T-Lymphocyte Abnormalities in the Wife of a Man Who Developed the Acquired Immunodeficiency Syndrome
32 Citations1985Harold Burger, BARBARA WEISER +8 more
Evidence of transmission of lymphadenopathy-associated virus (LAV)/human T-lymphotropic virus type III (HTLV-III) from a man to his wife, and a return to a normal number of T-helper lymphocytes and loss of antibody after discontinuing sexual exposure to LAV/HT LV-III is presented.
New England Journal of MedicinePrevalence of HTLV-III Infection among New Haven, Connecticut, Parenteral Drug Abusers in 1982–1983
17 Citations1986Richard T. D’Aquila, Ann B. Williams +2 more
This study confirms that HTLV-III infection is not unusual in asymptomatic parenteral drug abusers in areas of the urban northeastern US despite the few reported AIDS cases in admitted parentersal drug abuser.
The American Journal of MedicineTransmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners
15 Citations1986Harold Burger, Barbara Weiser +8 more
It is suggested that presence of lymphadenopathy-associated virus antibody does not always indicate a high degree of infectivity, and regular sexual contact with seropositive persons over long periods did not always lead to evidence of lymph Adenopathy- associated virus infection.